Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDJyong Biotech Ltd. Ordinary Shares Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 12/31/2024 | Q4 2024 | N/A | -$0.01 | N/A | N/A | $0 |
| 09/30/2024 | Q3 2024 | N/A | -$0.01 | N/A | N/A | $0 |
| 06/30/2024 | Q2 2024 | N/A | -$0.01 | N/A | N/A | $0 |
| 03/31/2024 | Q1 2024 | N/A | -$0.01 | N/A | N/A | $0 |
| 12/31/2023 | Q4 2023 | N/A | -$0.02 | N/A | N/A | $0 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Jyong Biotech Ltd. Ordinary Shares Earnings: FAQ's
The conference call for Jyong Biotech Ltd. Ordinary Shares's latest earnings report can be listened to online.
The conference call transcript for Jyong Biotech Ltd. Ordinary Shares's latest earnings report can be read online.
Jyong Biotech Ltd. Ordinary Shares (:MENS) has a recorded net income of $-3,019,000.Jyong Biotech Ltd. Ordinary Shares has generated $-0.0397 earnings per share over the last four quarters.
Jyong Biotech Ltd. Ordinary Shares (:MENS) has a price-to-earnings ratio of -881.22 and price/earnings-to-growth ratio is -63.5.